Arvinas Other Long Term Liabilities (Quarterly) Trends

Arvinas, Inc. (ARVN)

12.56 +0.27 (+2.20%) USD | NASDAQ | Jan 14, 12:13

View Other Long Term Liabilities (Quarterly) for ARVN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Verastem, Inc.	--
Genprex, Inc.	--
Olema Pharmaceuticals, Inc.	--